Evidence map›Paper›PMID 28216383›Full record

ArticleDevelopmental cell2017

Large-Scale Analysis of CRISPR/Cas9 Cell-Cycle Knockouts Reveals the Diversity of p53-Dependent Responses to Cell-Cycle Defects.

Kara L McKinley, Iain M Cheeseman

Open access · bronzeAbstract read
In one paragraph

Article in Developmental cell, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 134 papers.

0numbers the graph read from it
0cells of the map it votes in
134citing papers in PubMed
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

134 citing papers in PubMed, 208 citations in OpenAlex.

  1. Article
  2. Laboratory Assessment and Clinical Outlook forAnnals of laboratory medicine · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

74 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kara L McKinleyWhitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, MA 02142, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA. Electronic address: kara.l.mckinley@gmail.com.
Iain M CheesemanWhitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, MA 02142, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA. Electronic address: icheese@wi.mit.edu.
Whitehead Institute for Biomedical Research · US

Funding

Molecular Analysis of the Kinetochore-Microtubule InterfaceR01GM088313 · NIGMS · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI CHEESEMAN, IAIN MCPHERSON · 2009 to 2017
$3.6M
Molecular control of centromere specification and kinetochore assemblyR01GM108718 · NIGMS · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI CHEESEMAN, IAIN MCPHERSON · 2015 to 2017
$1.1M
NIGMS NIH HHS R01 GM088313NIGMS NIH HHS R01 GM108718
6 · The paper itself

Abstract

Defining the genes that are essential for cellular proliferation is critical for understanding organismal development and identifying high-value targets for disease therapies. However, the requirements for cell-cycle progression in human cells remain incompletely understood. To elucidate the consequences of acute and chronic elimination of cell-cycle proteins, we generated and characterized inducible CRISPR/Cas9 knockout human cell lines targeting 209 genes involved in diverse cell-cycle processes. We performed single-cell microscopic analyses to systematically establish the effects of the knockouts on subcellular architecture. To define variations in cell-cycle requirements between cultured cell lines, we generated knockouts across cell lines of diverse origins. We demonstrate that p53 modulates the phenotype of specific cell-cycle defects through distinct mechanisms, depending on the defect. This work provides a resource to broadly facilitate robust and long-term depletion of cell-cycle proteins and reveals insights into the requirements for cell-cycle progression.

Indexed as

Gene Knockout TechniquesCell CycleCell PolarityCell ProliferationCell SurvivalCellular SenescenceCentriolesCRISPR-Cas SystemsCyclin-Dependent Kinase Inhibitor p21HeLa CellsHumansPhenotypeSignal TransductionSpindle ApparatusTumor Suppressor Protein p53Cyclin-Dependent Kinase Inhibitor p21Tumor Suppressor Protein p53centromereCRISPR/Cas9DNA replicationkinetochoremicrotubulemitosismultipolarityp53spindle

Identifiers

PMID28216383
PMCPMC5345124
OpenAlexW2588526630

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.